ArticleJournal of epidemiology and global health2026
The Role of Mortality Surveillance in Case Detection and Response During the 2025 Sudan Virus Disease Outbreak in Uganda.
Article in Journal of epidemiology and global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeveloping countries like Uganda, face challenges in containing filovirus outbreaks such as Sudan virus disease (SVD). The 2025 Sudan Virus Disease outbreak in Uganda predominantly affected urban and peri-urban areas. To curtail the outbreak, mortality surveillance was integrated into the response strategies. This paper describes how mortality surveillance was implemented, its contribution to case detection and to the triggering of response actions, and the facilitators and barriers to its implementation during this outbreak.
methodsA retrospective descriptive document review was conducted, analyzing situation reports, meeting minutes, technical briefs, and mortality surveillance summaries generated by the Incident Management Team between the declaration of the outbreak (30 January 2025) and its official end (26 April 2025). We described the implementation processes, the contribution of mortality surveillance to case detection and response, and the facilitators and barriers to its implementation during the 2025 Sudan virus disease (SVD) outbreak.
resultsDuring the 2025 Sudan Virus Disease outbreak, mortality surveillance was rapidly activated and integrated into active surveillance. Mortality surveillance was conducted systematically involving the following community engagement; death notification; epidemiological investigations; and containment measures such as contact tracing, quarantine, and safe and dignified burials. Mortality surveillance contributed to case detection: 3/14 (21.4%) cases registered during the outbreak were identified through investigations triggered by death alerts. These detections informed public health measures such as contact tracing and quarantine of contacts, which may have contributed to interrupting potential transmission chains. Key facilitators included strong coordination and leadership, the use of digitized data tools, capacity building and community engagement and involvement. Persistent barriers included underreporting from informal settlements and private clinics, logistical delays in sample transportation, and lack of mortality surveillance guidelines during the outbreak.
conclusionThe 2025 Sudan virus disease outbreak in Uganda demonstrates the potential value of integrating mortality surveillance into outbreak detection and response, particularly in urban and informal settings. Strengthening mortality surveillance systems should be considered a core component of epidemic preparedness and response strategies in low- and middle-income countries facing recurrent filovirus threats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.